Erratum to: Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1:e00049. doi: 10.7554/eLife.00049;Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

eLife

Volumn 2012, Issue 1, 2012, Pages

  Yan, Huan ^a,b   Zhong, Guocai ^b   Xu, Guangwei ^b   He, Wenhui ^b,c   Jing, Zhiyi ^b   Gao, Zhenchao ^a,b   Huang, Yi ^b,c   Qi, Yonghe ^b   Peng, Bo ^b   Wang, Haimin ^b   Fu, Liran ^b,c   Song, Mei ^b,c   Chen, Pan ^b,c   Gao, Wenqing ^b   Ren, Bijie ^b   Sun, Yinyan ^b   Cai, Tao ^b   Feng, Xiaofeng ^b   Sui, Jianhua ^b   Li, Wenhui ^b  

^a PEKING UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CIRCULAR DNA; ENHANCED GREEN FLUORESCENT PROTEIN; ENVELOPE PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MESSENGER RNA; MUTANT PROTEIN; SMALL INTERFERING RNA; SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; UNCLASSIFIED DRUG; COTRANSPORTER; ORGANIC ANION TRANSPORTER; PEPTIDE; PROTEIN BINDING; SODIUM-BILE ACID COTRANSPORTER; TAUROCHOLIC ACID; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BIOINFORMATICS; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; HELA CELL; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LIVER CELL; LIVER CELL CARCINOMA; MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANDENTIA; SOUTHERN BLOTTING; VIRUS INFECTION; VIRUS INHIBITION; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMISTRY; GENE EXPRESSION; GENETICS; LIVER; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHOTOCHEMISTRY; PRIMARY CELL CULTURE; PROTEIN TERTIARY STRUCTURE; TRANSPORT AT THE CELLULAR LEVEL; VIROLOGY; VIRUS ENTRY;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; GENE EXPRESSION; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HEPATOCYTES; HUMANS; LIVER; MOLECULAR SEQUENCE DATA; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PEPTIDES; PHOTOCHEMICAL PROCESSES; PRIMARY CELL CULTURE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; SYMPORTERS; TAUROCHOLIC ACID; TUPAIA; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84879327902     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.05570     Document Type: Erratum

References (56)

1. Barrera A, Guerra B, Lee H, Lanford RE. 2004. Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes. J Virol 78:5233-43.
2. Barrera A, Guerra B, Notvall L, Lanford RE. 2005. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J Virol 79:9786-98.
3. Blanchet M, Sureau C. 2006. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J Virol 80:11935-45.
4. Blanchet M, Sureau C. 2007. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol 81:5841-9.
5. Boehm ST, Thasler WE, Weiss TS, Jilg W. 2005. Primary human hepatocytes as an in vitro model for hepatitis B virus infection. In: Von Weizsäcker F, Roggendorf M, editors. Models of viral hepatitis, Vol 25. Basel: Karger; p. 119-34.
6. Bowden S, Jackson K, Littlejohn M, Locarnini S. 2004. Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR. Methods Mol Med 95:41-50.
7. Burge C, Karlin S. 1997. 2009. Prediction of complete gene structures in human genomic DNA. J Mol Biol 268:78-94.
8. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. 2009. BLAST+: architecture and applications. BMC Bioinformatics 10:421.
9. Chen PJ, Kalpana G, Goldberg J, Mason W, Werner B, Gerin J, et al. 1986. Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci USA 83:8774-8.
10. Chouteau P, Le Seyec J, Cannie I, Nassal M, Guguen-Guillouzo C, Gripon P. 2001. A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus. J Virol 75:11565-72.
11. Engelke M, Mills K, Seitz S, Simon P, Gripon P, Schnölzer M, et al. 2006. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology 43:750-60.
12. Freitas N, Salisse J, Cunha C, Toshkov I, Menne S, Gudima SO. 2012. Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks. Hepatology 56:76-85.
13. Glebe D, Aliakbari M, Krass P, Knoop EV, Valerius KP, Gerlich WH. 2003. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol 77:9511-21.
14. Glebe D, Urban S, Knoop EV, Cag N, Krass P, Grün S, et al. 2005. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and Tupaia hepatocytes. Gastroenterology 129:234-45.
15. Glebe D, Urban S. 2007. Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13:22-38.
16. Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, Amit I, et al. 2011. Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat Biotechnol 29:644-52.
17. Gripon P, Diot C, Thézé N, Fourel I, Loreal O, Brechot C, et al. 1988. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol 62(11):4136-43.
18. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, et al. 2002. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 99:15655-60.
19. Gripon P, Diot C, Guguen-Guillouzo C. 1993. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 192:534-40.
20. Gripon P, Le Seyec J, Rumin S, Guguen-Guillouzo C. 1995. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 213:292-9.
21. Gripon P, Cannie I, Urban S. 2005. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol 79:1613-22.
22. Hagenbuch B, Meier PJ. 1994. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest 93:1326-31.
23. Hart SN, Li Y, Nakamoto K, Subileau EA, Steen D, Zhong XB. 2010. A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug Metab Dispos 38:988-94.
24. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. 1984. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 52:396-402.
25. Hu NJ, Iwata S, Cameron AD, Drew D. 2011. Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT. Nature 478:408-11.
26. Hughes SA, Wedemeyer H, Harrison PM. 2011. Hepatitis delta virus. Lancet 378:73-85.
27. Kullak-Ublick GA, Glasa J, Böker C, Oswald M, Grützner U, Hagenbuch B, et al. 1997. Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology 113:1295-305.
28. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11:97-107.
29. Le Duff Y, Blanchet M, Sureau C. 2009. The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent. J Virol 83:12443-51.
30. Le Seyec J, Chouteau P, Cannie I, Guguen-Guillouzo C, Gripon P. 1999. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J Virol 73:2052-7.
31. Lee S, Kim S. 2007. Gene regulations in HBV-related liver cirrhosis closely correlate with disease severity. J Biochem Mol Biol 40:814-24.
32. Leistner CM, Gruen-Bernhard S, Glebe D. 2008. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol 10:122-33.
33. Liang D, Hagenbuch B, Stieger B, Meier PJ. 1993. Parallel decrease of Na(+)-taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes. Hepatology 18:1162-6.
34. Mareninova O, Shin JM, Vagin O, Turdikulova S, Hallen S, Sachs G. 2005. Topography of the membrane domain of the liver Na+-dependent bile acid transporter. Biochemistry 44:13702-12.
35. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, et al. 2005. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 33:D284-8. Database issue.
36. Morizono K, Xie Y, Olafsen T, Lee B, Dasgupta A, Wu AM, et al. 2011. The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell Host Microbe 9:286-98.
37. Rippin SJ, Hagenbuch B, Meier PJ, Stieger B. 2001. Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes. Hepatology 33:776-82.
38. Schulze A, Gripon P, Urban S. 2007. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46:1759-68.
39. Schulze A, Schieck A, Ni Y, Mier W, Urban S. 2010. Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction. J Virol 84:1989-2000.
40. Seeger C, Zoulin F, Mason WS. 2007. Hepadnaviruses. In: Knipe DM, Howley PM, editors. Field's virology, 5th Ed, Vol 2. Philadelphia: Lippincott, Williams, and Wilkins; p. 2977.
41. Shayakhmetov DM, Gaggar A, Ni S, Li ZY, Lieber A. 2005. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 79:7478-91.
42. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. 2006. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1:2856-60.
43. Stieger B, Hagenbuch B, Landmann L, Höchli M, Schroeder A, Meier PJ. 1994. In situ localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liver. Gastroenterology 107:1781-7.
44. Stieger B. 2011. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol 205-59.
45. Su JJ, Yan RQ, Gan YQ, Zhou DN, Huang GH. 1987. [Experimental infection of human hepatitis B virus (HBV) in adult tree shrews]. Zhonghua Bing Li Xue Za Zhi 16:103-6.
46. Suchanek M, Radzikowska A, Thiele C. 2005. Photo-leucine and photo-methionine allow identification of protein-protein interactions in living cells. Nat Methods 2:261-7.
47. Sui J, Li W, Roberts A, Matthews LJ, Murakami A, Vogel L, et al. 2005. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J Virol 79:5900-6.
48. Summers J, Smith PM, Horwich AL. 1990. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 64:2819-24.
49. Sureau C, Moriarty AM, Thornton GB, Lanford RE. 1992. Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens. J Virol 66:1241-5.
50. Sureau C. 2006. The role of the HBV envelope proteins in the HDV replication cycle. Curr Top Microbiol Immunol 307:113-31.
51. Tabb DL, McDonald WH, Yates JR III. 2002. DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J Proteome Res 1:21-6.
52. Walter E, Keist R, Niederost B, Pult I, Blum HE. 1996. Hepatitis B virus infection of Tupaia hepatocytes in vitro and in vivo. Hepatology 24:1-5.
53. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, et al. 2004. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126:1750-8.
54. Xiao X, Li J, Samulski RJ. 1998. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72:2224-32.
55. Xu T, Venable JD, Park SK, Cociorva D, Lu B, Liao L, et al. 2006. ProLuCID, a fast and sensitive tandem mass spectra-based protein identification program. Mol Cell Proteomics 5:S174.
56. Zollner G, Wagner M, Fickert P, Silbert D, Fuchsbichler A, Zatloukal K, et al. 2005. Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int 25:367-79.